Eli Lilly has begun the week with a bang. Early Monday morning, AdvanCell and OliX Pharmaceuticals put out news that the Big ...
GlobalData on MSN3d
Eli Lilly pledges $630m on OliX’s Phase I RNA candidate for MASHLilly will provide an initial payment to complete a Phase I trial of OLX75016, which started in February 2024.
This innovative program addresses global health initiatives and medical training in Peru with Partners in Health, known ...
They also discovered that cigarette use declined among a subgroup of smokers in the study, lending weight to the hypothesis ...
Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...
BOSTON, MA, UNITED STATES, February 13, 2025 /EINPresswire / -- When Ruihua Liu founded Hill Research, the goal was clear: to revolutionize clinical trials using Generative AI. With a background in ...
Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived ...
Doctors have begun noticing a trend: they all seem to get full before finishing dinner, and it's likely thanks to drugs like ...
A small semaglutide trial suggests the medicine's suppression of appetite may extend to alcohol, but larger tests are needed ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback